Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma

Chenyang Wang, Tania B. Kaprealian, John H. Suh, Charlotte D. Kubicky, Jeremy Ciporen, Yiyi Chen, Jerry Jaboin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background. Adjuvant radiotherapy (RT) after surgical resection of World Health Organization (WHO) grade II meningioma, also known as atypical meningioma (AM), is a topic of controversy. The purpose of this study is to compare overall survival (OS) with or without adjuvant RT after subtotal resection (STR) or gross total resection (GTR) in AM patients diagnosed according to the 2007 WHO classification. Methods. The National Cancer Database was used to identify 2515 patients who were diagnosed with AM between 2009 and 2012 and underwent STR or GTR with or without adjuvant RT. Propensity score matching was first applied to balance covariates including age, year of diagnosis, sex, race, histology, and tumor size in STR or GTR cohorts stratified by adjuvant RT status. Multivariate regression according to the Cox proportional hazards model and Kaplan-Meier survival plots with log-rank test were then used to evaluate OS difference associated with adjuvant RT. Results. GTR is associated with improved OS compared with STR. In the subgroup analysis, adjuvant RT in patients who underwent STR demonstrated significant association with improved OS compared with no adjuvant RT (adjusted hazard ratio [AHR] 0.590, P = .045); however, adjuvant RT is not associated with improved OS in patients who underwent GTR (AHR 1.093, P = .737). Conclusions. Despite the lack of consensus on whether adjuvant RT reduces recurrence after surgical resection of AM, our study observed significantly improved OS with adjuvant RT compared with no adjuvant RT after STR.

Original languageEnglish (US)
Pages (from-to)1263-1270
Number of pages8
JournalNeuro-Oncology
Volume19
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Adjuvant Radiotherapy
Meningioma
Survival
Propensity Score
Proportional Hazards Models
Neoplasms
Histology
Databases

Keywords

  • Adjuvant radiotherapy
  • NCDB
  • Overall survival
  • Propensity score
  • WHO grade II meningioma

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. / Wang, Chenyang; Kaprealian, Tania B.; Suh, John H.; Kubicky, Charlotte D.; Ciporen, Jeremy; Chen, Yiyi; Jaboin, Jerry.

In: Neuro-Oncology, Vol. 19, No. 9, 01.09.2017, p. 1263-1270.

Research output: Contribution to journalArticle

Wang, Chenyang ; Kaprealian, Tania B. ; Suh, John H. ; Kubicky, Charlotte D. ; Ciporen, Jeremy ; Chen, Yiyi ; Jaboin, Jerry. / Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. In: Neuro-Oncology. 2017 ; Vol. 19, No. 9. pp. 1263-1270.
@article{22813ccc7b1f47be8dab9cf5fa170401,
title = "Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma",
abstract = "Background. Adjuvant radiotherapy (RT) after surgical resection of World Health Organization (WHO) grade II meningioma, also known as atypical meningioma (AM), is a topic of controversy. The purpose of this study is to compare overall survival (OS) with or without adjuvant RT after subtotal resection (STR) or gross total resection (GTR) in AM patients diagnosed according to the 2007 WHO classification. Methods. The National Cancer Database was used to identify 2515 patients who were diagnosed with AM between 2009 and 2012 and underwent STR or GTR with or without adjuvant RT. Propensity score matching was first applied to balance covariates including age, year of diagnosis, sex, race, histology, and tumor size in STR or GTR cohorts stratified by adjuvant RT status. Multivariate regression according to the Cox proportional hazards model and Kaplan-Meier survival plots with log-rank test were then used to evaluate OS difference associated with adjuvant RT. Results. GTR is associated with improved OS compared with STR. In the subgroup analysis, adjuvant RT in patients who underwent STR demonstrated significant association with improved OS compared with no adjuvant RT (adjusted hazard ratio [AHR] 0.590, P = .045); however, adjuvant RT is not associated with improved OS in patients who underwent GTR (AHR 1.093, P = .737). Conclusions. Despite the lack of consensus on whether adjuvant RT reduces recurrence after surgical resection of AM, our study observed significantly improved OS with adjuvant RT compared with no adjuvant RT after STR.",
keywords = "Adjuvant radiotherapy, NCDB, Overall survival, Propensity score, WHO grade II meningioma",
author = "Chenyang Wang and Kaprealian, {Tania B.} and Suh, {John H.} and Kubicky, {Charlotte D.} and Jeremy Ciporen and Yiyi Chen and Jerry Jaboin",
year = "2017",
month = "9",
day = "1",
doi = "10.1093/neuonc/nox007",
language = "English (US)",
volume = "19",
pages = "1263--1270",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma

AU - Wang, Chenyang

AU - Kaprealian, Tania B.

AU - Suh, John H.

AU - Kubicky, Charlotte D.

AU - Ciporen, Jeremy

AU - Chen, Yiyi

AU - Jaboin, Jerry

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Background. Adjuvant radiotherapy (RT) after surgical resection of World Health Organization (WHO) grade II meningioma, also known as atypical meningioma (AM), is a topic of controversy. The purpose of this study is to compare overall survival (OS) with or without adjuvant RT after subtotal resection (STR) or gross total resection (GTR) in AM patients diagnosed according to the 2007 WHO classification. Methods. The National Cancer Database was used to identify 2515 patients who were diagnosed with AM between 2009 and 2012 and underwent STR or GTR with or without adjuvant RT. Propensity score matching was first applied to balance covariates including age, year of diagnosis, sex, race, histology, and tumor size in STR or GTR cohorts stratified by adjuvant RT status. Multivariate regression according to the Cox proportional hazards model and Kaplan-Meier survival plots with log-rank test were then used to evaluate OS difference associated with adjuvant RT. Results. GTR is associated with improved OS compared with STR. In the subgroup analysis, adjuvant RT in patients who underwent STR demonstrated significant association with improved OS compared with no adjuvant RT (adjusted hazard ratio [AHR] 0.590, P = .045); however, adjuvant RT is not associated with improved OS in patients who underwent GTR (AHR 1.093, P = .737). Conclusions. Despite the lack of consensus on whether adjuvant RT reduces recurrence after surgical resection of AM, our study observed significantly improved OS with adjuvant RT compared with no adjuvant RT after STR.

AB - Background. Adjuvant radiotherapy (RT) after surgical resection of World Health Organization (WHO) grade II meningioma, also known as atypical meningioma (AM), is a topic of controversy. The purpose of this study is to compare overall survival (OS) with or without adjuvant RT after subtotal resection (STR) or gross total resection (GTR) in AM patients diagnosed according to the 2007 WHO classification. Methods. The National Cancer Database was used to identify 2515 patients who were diagnosed with AM between 2009 and 2012 and underwent STR or GTR with or without adjuvant RT. Propensity score matching was first applied to balance covariates including age, year of diagnosis, sex, race, histology, and tumor size in STR or GTR cohorts stratified by adjuvant RT status. Multivariate regression according to the Cox proportional hazards model and Kaplan-Meier survival plots with log-rank test were then used to evaluate OS difference associated with adjuvant RT. Results. GTR is associated with improved OS compared with STR. In the subgroup analysis, adjuvant RT in patients who underwent STR demonstrated significant association with improved OS compared with no adjuvant RT (adjusted hazard ratio [AHR] 0.590, P = .045); however, adjuvant RT is not associated with improved OS in patients who underwent GTR (AHR 1.093, P = .737). Conclusions. Despite the lack of consensus on whether adjuvant RT reduces recurrence after surgical resection of AM, our study observed significantly improved OS with adjuvant RT compared with no adjuvant RT after STR.

KW - Adjuvant radiotherapy

KW - NCDB

KW - Overall survival

KW - Propensity score

KW - WHO grade II meningioma

UR - http://www.scopus.com/inward/record.url?scp=85028401771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028401771&partnerID=8YFLogxK

U2 - 10.1093/neuonc/nox007

DO - 10.1093/neuonc/nox007

M3 - Article

C2 - 28371851

AN - SCOPUS:85028401771

VL - 19

SP - 1263

EP - 1270

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 9

ER -